Difference between revisions of "Template:Cite pmid/11709512"
From Self-sufficiency
m (Citation maintenance. [143]Added: first2. User-activated.) |
m (1 revision) |
(No difference)
| |
Latest revision as of 12:17, 20 September 2010
Kruis, W; Schreiber, I; Theuer; Brandes; Schütz; Howaldt; Krakamp; Hämling; Mönnikes (2001). "Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses". Gut. 49 (6): 783–9. doi:10.1136/gut.49.6.783. PMC 1728533 Freely accessible. PMID 11709512. More than one of|author2= and |last2= specified (help); More than one of |author3= and |last3= specified (help); More than one of |author4= and |last4= specified (help); More than one of |author5= and |last5= specified (help); More than one of |author6= and |last6= specified (help); More than one of |author7= and |last7= specified (help); More than one of |author8= and |last8= specified (help); More than one of |author9= and |last9= specified (help)[edit]
Documentation
